A NOVEL GENE, TRANSLIN, ENCODES A RECOMBINATION HOTSPOT BINDING-PROTEIN ASSOCIATED WITH CHROMOSOMAL TRANSLOCATIONS

被引:187
作者
AOKI, K
SUZUKI, K
SUGANO, T
TASAKA, T
NAKAHARA, K
KUGE, O
OMORI, A
KASAI, M
机构
[1] NATL INST HLTH,DEPT IMMUNOL,SHINJUKU KU,TOKYO 162,JAPAN
[2] NATL INST HLTH,DEPT PATHOL,SHINJUKU KU,TOKYO 162,JAPAN
[3] NATL INST HLTH,DEPT BIOCHEM & CELL BIOL,SHINJUKU KU,TOKYO 162,JAPAN
[4] UNIV TOKYO,SCH MED,DEPT INTERNAL MED,BUNKYO KU,TOKYO 113,JAPAN
[5] KYORIN UNIV,SCH MED,DEPT CLIN PATHOL,MITAKA 181,TOKYO,JAPAN
[6] MITSUBISHI KASEI INST LIFE SCI,MACHIDA,TOKYO 194,JAPAN
关键词
D O I
10.1038/ng0695-167
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have identified a novel gene, Translin, encoding a protein which specifically binds to consensus sequences at breakpoint junctions of chromosomal translocations in many cases of lymphoid malignancies. The encoded protein, Translin, is a previously undescribed type with no significant similarity to known proteins. In the native-form, Translin polypeptides form a multimeric structure which is responsible for its DNA binding activity. Nuclear localization of Translin is limited to lymphoid cell lines, raising the intriguing possibility that nuclear transport of Translin is regulated in a physiologically significant way such that active nuclear transport is associated with the lymphoid specific process known as Ig/TCR gene rearrangement.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 63 条
  • [1] Maziarz R.T., Et al., A/+ T cell leukemia bearing a novel t(8
  • [2] 14)(q24
  • [3] q11) translocation demonstrates spontaneous in vitro natural killer-like activity, Blood, 79, pp. 1523-1531, (1992)
  • [4] Kasai M., Maziarz R.T., Aoki K., Macintyre E., Strominger J.L., Involvement of the pvt-1 locus in a/T-cell leukemia bearing a variant t(8
  • [5] 14)(q24
  • [6] q11) translocation, Molec. Cell. Biol, 12, pp. 4751-4757, (1992)
  • [7] Kasai M., Et al., Recombination hotspot associated factors specifically recognize novel target sequences at the site of interchromosomal rearrangements in T-ALL patients with t(8
  • [8] 14)(q24
  • [9] q11) and t(1
  • [10] 14)(p32